Next Article in Journal
Rehabilitative Exercise Reduced the Impact of Peripheral Artery Disease on Vascular Outcomes in Elderly Patients with Claudication: A Three-Year Single Center Retrospective Study
Next Article in Special Issue
The Ideal Goal of Testosterone Replacement Therapy: Maintaining Testosterone Levels or Managing Symptoms?
Previous Article in Journal
Oral Bicarbonate Therapy in Non-Haemodialysis Dependent Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Previous Article in Special Issue
Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessReview
J. Clin. Med. 2019, 8(2), 209;

The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism

Department of Urology, Chonbuk National University Medical School, Jeonju 54907, Korea
Research Institute of Clinical Medicine, Chonbuk National University, Jeonju 54907, Korea
Biomedical Research Institute, Chonbuk National University Hospital, Jeonju 54907, Korea
Clinical Trial Center of Medical Device, Chonbuk National University Hospital, Jeonju 54907, Korea
Author to whom correspondence should be addressed.
Received: 2 January 2019 / Revised: 1 February 2019 / Accepted: 3 February 2019 / Published: 7 February 2019
(This article belongs to the Special Issue Testosterone and Men’s Health: From Evidence to Clinical Practice)
Full-Text   |   PDF [423 KB, uploaded 18 February 2019]   |  
  |   Review Reports


The use of testosterone replacement therapy (TRT) for late-onset hypogonadism (LOH) is increasing every year; however, the literature shows that many men are using testosterone (T) without a clear indication. Previous studies have estimated that up to 25% of men who receive TRT do not have their T tested prior to initiation of the therapy. Given the growing concern and need for proper TRT, clinicians need evidence-based information that informs them on the optimal indication for TRT in LOH patients. The diagnosis of LOH requires the presence of characteristic signs and symptoms, in combination with decreased serum total testosterone (TT). Based on the recent guidelines by the International Society for the Study of Aging Male (ISSAM), the European Association of Urology (EAU), the European Society of Endocrinology (ESE), the European Academy of Andrology (EAA), and the American Association of Urology (AUA), a TT of 250–350 ng/dL is the proper threshold value to define low T. The optimal indication for TRT in LOH is the presence of signs and symptoms of hypogonadism, and low T without contraindications for TRT. View Full-Text
Keywords: indication; hypogonadism; testosterone indication; hypogonadism; testosterone

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Shin, Y.S.; Park, J.K. The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism. J. Clin. Med. 2019, 8, 209.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top